Distinct domains of IκB-α inhibit human immunodeficiency virus type 1 replication through NF-κB and Rev

Journal of Virology

Volumn 71, Issue 4, 1997, Pages 3161-3167

  Wu, Bei Yue ^a   Woffendin, Clive ^a   MacLachlan, Ian ^a,b   Nabel, Gary J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b NEX Pharmaceuticals   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN KAPPA CHAIN; REV PROTEIN; TRANSCRIPTION FACTOR; DNA BINDING PROTEIN; I KAPPA B; I KAPPA B BETA; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS; TRANSCRIPTION REGULATION; VIRUS REPLICATION; BINDING SITE; CELL LINE; CELL NUCLEUS; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

BINDING SITES; CELL LINE, TRANSFORMED; CELL NUCLEUS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, REV; HIV-1; HUMANS; I-KAPPA B PROTEINS; JURKAT CELLS; NF-KAPPA B; SIGNAL TRANSDUCTION; VIRUS REPLICATION;

EID: 0030615020     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.4.3161-3167.1997     Document Type: Article

References (45)

1. Alkalay, I., A. Yaron, A. Hatzubai, A. Orian, A. Ciechanover, and Y. Ben-Neriah. 1995. Stimulation-dependent IκB-a phosphorylation marks the NF-κB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 92:10599-10603.
2. Baeuerle, P. A., and D. Baltimore. 1988. IκB: a specific inhibitor of the NF-κB transcription factor. Science 242:540-546.
3. Barroga, C. F., J. K. Stevenson, E. M. Schwarz, and I. M. Verma. 1995. Constitutive phosphorylation of IκBa by casein kinase II. Proc. Natl. Acad. Sci. USA 92:7637-7641.
4. Bevec, D., H. Jaksche, M. Oft, T. Wohl, M. Himmelspach, A. Pacher, M. Schebesta, K. Koettnitz, M. Dobrovnik, R. Csonga, F. Lottspeich, and J. Hauber. 1996. Inhibition of HIV-1 replication in lymphocytes by mutants of the Rev cofactor eIF-5A. Science 271:1858-1860.
5. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-a proteolysis by site-specific, signal-induced phosphorylation, Science 267:1485-1488.
6. Chen, Z., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBa to the ubiquitin-proteasome pathway. Genes Dev. 9:1586-1597.
7. Chen, Z. J., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IκBa by a novel ubiquitination-dependent protein kinase activity. Cell 84:853-862.
8. Cullen, B. R., and M. H. Malim. 1991. The HIV-1 Rev protein: prototype of a novel class of eukaryotic post-transcriptional regulators. Trends Biochem. Sci. 16:346-350.
9. Finco, T. S., A. A. Beg, and A. S. Baldwin, Jr. 1994. Inducible phosphorylation of IκBa is not sufficient for its dissociation from NF-κB and is inhibited by protease inhibitors. Proc. Natl. Acad. Sci. USA 91:11884-11888.
10. Fischer, U., J. Huber, W. C. Boelens, I. W. Mattaj, and R. Luhrmann. 1995. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82:475-483.
11. Fritz, C. C., and M. R. Green. 1996. HIV Rev uses a conserved cellular protein export pathway for the nucleocytoplasmic transport of viral RNAs. Curr. Biol. 6:848-854.
12. Fritz, C. C., M. L. Zapp, and M. R. Green. 1995. A human nucleoporin-like protein that specifically interacts with HIV Rev. Nature 376:530-533.
13. Ghosh, S., and D. Baltimore. 1990. Activation in vitro of NF-κB by phosphorylation of its inhibitor IκB. Nature 344:678-682.
14. Gorman, C., R. Padmanabhan, and B. H. Howard. 1983. High efficiency DNA-mediated transformation of primate cells. Science 221:551-553.
15. Hatada, E. N., M. Naumann, and C. Scheidereit. 1993. Common structural constituents confer IκB activity to NF-κB p105 and IκB/MAD-3. EMBO J. 12:2781-2788.
16. Israel, A. 1995. A role for phosphorylation and degradation in the control of NF-κB B activity. Trends Genet. 11:203-205.
17. Leung, K., and G. J. Nabel. 1988. HTLV-I transactivator induces interleukin-2 receptor expression through an NF-κB-like factor. Nature 333:776-778.
18. Lin, Y., K. Brown, and U. Siebenlist. 1995. Activation of NF-κB requires proteolysis of the inhibitor IκB-a: signal induced phosphorylation of IκB-a alone does not release active NF-κB. Proc. Natl. Acad. Sci. USA 92:552-556.
19. Link, E., L. D. Kerr, R. Schreck, U. Zabel, I. Verma, and P. A. Baeuerle. 1992. Purified I kappa B-beta is inactivated upon dephosphorylation. J. Biol. Chem. 267:239-246.
20. Liu, J., C. Woffendin, Z. Yang, and G. J. Nabel. 1994. Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells. Gene Ther. 1:32-37.
21. Malim, M. H., S. Bohnlein, J. Hauber, and B. R. Cullen. 1989. Functional dissection of the HIV-1 Rev trans-activator - derivation of a trans-dominant repressor of Rev function. Cell 58:205-214.
22. Malim, M. H., and B. R. Cullen. 1991. HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell 65:241-248.
23. Malim, M. H., J. Hauber, S. Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 Rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338:254-257.
24. Malim, M. H., D. F. McCarn, L. S. Tiley, and B. R. Cullen. 1991. Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J. Virol. 65:4248-4254.
25. Matthews, J. R., and R. T. Hay. 1995. Regulation of the DNA binding activity of NF-κB. Int. J. Biochem. Cell Biol. 27:865-879.
26. McElhinny, J. A., S. A. Trushin, G. D. Bren, N. Chester, and C. V. Paya. 1996. Casin kinase II phosphorylates IκB-α at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol. 16:899-906.
27. Meyer, B. E., and M. H. Malim. 1994. The HIV-1 Rev trans-activator shuttles between the nucleus and the cytoplasm. Genes Dev. 8:1538-1547.
28. Miyamoto, S., M. Maki, M. J. Schmitt, M. Hatanaka, and I. M. Verma. 1994. Tumor necrosis factor alpha-induced phosphorylation of IκB-a is a signal for its degradation but not dissociation from NF-κB. Proc. Natl. Acad. Sci. USA 91:12740-12744.
29. Miyamoto, S., and I. M. Verma. 1995. Rel/NF-αB/IκB story. Adv. Cancer Res. 66:255-292.
30. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713.
31. Potts, B. J. 1990. Mini reverse transcriptase assay, p. 103-106. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, New York, N.Y.
32. Rechsteiner, M., and S. W. Rogers. 1996. PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21:267-271.
33. Ruhl, M., M. Himmelspach, G. M. Bahr, F. Hammerschmid, H. Jaksche, B. Wolff, H. Aschauer, G. K. Farrington, H. Probst, D. Bevec, and J. Hauber. 1993. Eukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 rev activation domain mediating trans-activation. J. Cell Biol. 123:1309-1320.
34. Scherer, D. C., J. A. Brockman, Z. Chen, T. Maniatis, and D. W. Ballard. 1995. Signal-induced degradation of IκB-a requires site-specific ubiquitination. Proc. Natl. Acad. Sci. USA 92:11259-11263.
35. Schmitz, M. L., and P. A. Baeuerle. 1995. Multi-step activation of NF-κB/Rel transcription factors. Immunobiology 193:116-127.
36. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10:405-455.
37. Stutz, F., M. Neville, and M. Rosbash. 1995. Identification of a novel nuclear pore-associated protein as a functional target of the HIV-1 protein in yeast. Cell 82:495-506.
38. Sun, S., J. Elwood, and W. C. Greene. 1996. Both amino-and carboxylterminal sequences within IκB-α regulate its inducible degradation. Mol. Cell. Biol. 16:1058-1065.
39. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
40. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-b regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573-582.
41. Urban, M. B., and P. A. Baeuerle. 1990. The 65-kD subunit of NF-κB is a receptor for IκB and a modulator of DNA-binding specificity. Genes Dev. 4:1975-1984.
42. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. V. Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
43. Wen, W., J. L. Meinkoth, R. Y. Tsien, and S. S. Taylor. 1995. Identification of a signal for rapid export of proteins from the nucleus. Cell 82:463-473.
44. Wu, B., C. Woffendin, C. S. Duckett, T. Ohno, and G. J. Nabel. 1995. Regulation of human retroviral latency by the NF-κB/IκB family: inhibition of human immunodeficiency virus replication by IκB through a Rev-dependent mechanism. Proc. Natl. Acad. Sci. USA 92:1480-1484.
45. Zabel, U., and P. A. Baeuerle. 1990. Purified human I kappa B can rapidly dissociate the complex of the NF-kappa B transcription factor with its cognate DNA. Cell 61:255-265.